The UF Fixel Institute is a site participating in the GENERATION HD2 trial, sponsored by Roche-Genentech. This trial is studying an investigational drug (Tominersen) designed to target the Huntingin protein. See the following for more information:
Contact info: Randy.Foli@neurology.ufl.edu
